Cargando…

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum

OBJECTIVE: To examine the clinical value of neurofilament light chain (NfL) and the phospho-tau/total tau ratio (p/t-tau) across the entire frontotemporal dementia (FTD) spectrum in a large, well-defined cohort. METHODS: CSF NfL and p/t-tau levels were studied in 361 patients with FTD: 179 behaviora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meeter, Lieke H.H., Vijverberg, Everard G., Del Campo, Marta, Rozemuller, Annemieke J.M., Donker Kaat, Laura, de Jong, Frank Jan, van der Flier, Wiesje M., Teunissen, Charlotte E., van Swieten, John C., Pijnenburg, Yolande A.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890612/ https://www.ncbi.nlm.nih.gov/pubmed/29514947 http://dx.doi.org/10.1212/WNL.0000000000005261

Ejemplares similares

Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes
por: Pijnenburg, Yolande A.L., et al.
Publicado: (2015)

Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia
por: Giannini, Lucia A.A., et al.
Publicado: (2023)

Urine as matrix for analysis of neurofilament light chain is not suitable to distinguish frontotemporal dementia from psychiatric diseases
por: van Engelen, Marie-Paule E, et al.
Publicado: (2023)

Neurofilament light chain: a biomarker for genetic frontotemporal dementia
por: Meeter, Lieke H., et al.
Publicado: (2016)

Clinical Phenotypes of Behavioral Variant Frontotemporal Dementia by Age at Onset
por: Fieldhouse, Jay L.P., et al.
Publicado: (2021)

Psychosis in behavioral variant frontotemporal dementia
por: Gossink, Flora T, et al.
Publicado: (2017)

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
por: Goossens, Joery, et al.
Publicado: (2018)

Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration
por: Giannini, Lucia A. A., et al.
Publicado: (2022)

Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics
por: Teunissen, Charlotte E., et al.
Publicado: (2016)

Correction to: Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration
por: Giannini, Lucia A. A., et al.
Publicado: (2023)

Age‐ and disease‐specific reference values for neurofilament light presented in an online interactive support interface
por: Vermunt, Lisa, et al.
Publicado: (2022)

The role of neurofilament light in genetic frontotemporal lobar degeneration
por: Zetterberg, Henrik, et al.
Publicado: (2022)

Effect of long-term storage in biobanks on cerebrospinal fluid biomarker Aβ(1-42), T-tau, and P-tau values
por: Willemse, Eline A.J., et al.
Publicado: (2017)

YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer’s disease and frontotemporal lobar degeneration
por: Hok-A-Hin, Yanaika S., et al.
Publicado: (2022)

Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory
por: de Haan, Willem, et al.
Publicado: (2009)

Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology
por: Scarioni, Marta, et al.
Publicado: (2020)

Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia
por: Jiskoot, Lize C, et al.
Publicado: (2019)

The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series
por: Ulugut Erkoyun, Hulya, et al.
Publicado: (2021)

Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers
por: Meeter, Lieke H.H., et al.
Publicado: (2016)

Longitudinal cognitive biomarkers predicting symptom onset in presymptomatic frontotemporal dementia
por: Jiskoot, Lize C., et al.
Publicado: (2018)

Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders
por: Vijverberg, Everard G.B., et al.
Publicado: (2017)

Novel TUBA4A Variant Associated With Familial Frontotemporal Dementia
por: Mol, Merel O., et al.
Publicado: (2021)

Unfolded protein response activation in C9orf72 frontotemporal dementia is associated with dipeptide pathology and granulovacuolar degeneration in granule cells
por: Gami‐Patel, Priya, et al.
Publicado: (2020)

Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
por: Bayoumy, Sherif, et al.
Publicado: (2021)

Addition of the FTD Module to the Neuropsychiatric Inventory improves classification of frontotemporal dementia spectrum disorders
por: Jiskoot, Lize C., et al.
Publicado: (2023)

Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights
por: Scarioni, Marta, et al.
Publicado: (2022)

Cognitive profiles discriminate between genetic variants of behavioral frontotemporal dementia
por: Poos, J. M., et al.
Publicado: (2020)

Schizophrenia as a mimic of behavioral variant frontotemporal dementia
por: Kerssens, Cora J., et al.
Publicado: (2016)

Right temporal variant frontotemporal dementia is pathologically heterogeneous: a case-series and a systematic review
por: Ulugut, Hulya, et al.
Publicado: (2021)

Correction to: Cognitive profiles discriminate between genetic variants of behavioral frontotemporal dementia
por: Poos, J. M., et al.
Publicado: (2020)

Distinctive pattern of temporal atrophy in patients with frontotemporal dementia and the I383V variant in TARDBP
por: Mol, Merel O., et al.
Publicado: (2021)

Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies
por: del Campo, Marta, et al.
Publicado: (2021)

Altered brain metabolism in frontotemporal dementia and psychiatric disorders: involvement of the anterior cingulate cortex
por: van Engelen, Marie-Paule E., et al.
Publicado: (2023)

Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals
por: Groot, Colin, et al.
Publicado: (2022)

Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons
por: Hoe, Hyang-Sook, et al.
Publicado: (2006)

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology
por: DeFelipe, Javier
Publicado: (2016)

Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy
por: Kimura, Taeko, et al.
Publicado: (2018)

The study of Tau and phospho Tau protein levels in attention deficit and hyperactivity disorder
por: SARAÇOĞLU, Hatice, et al.
Publicado: (2021)

Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
por: Marksteiner, Josef, et al.
Publicado: (2022)

Plasma tau is increased in frontotemporal dementia
por: Foiani, Martha S, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ujeivke4ns5vlhk1h4fatgc644